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Background and purpose: We evaluated the accuracy of three methods of estimating radiation dose to the
heart from two-dimensional tangential radiotherapy for breast cancer, as used in Denmark during 1982–
2002.
Material and methods: Three tangential radiotherapy regimens were reconstructed using CT-based plan-
ning scans for 40 patients with left-sided and 10 with right-sided breast cancer. Setup errors and organ
motion were simulated using estimated uncertainties. For left-sided patients, mean heart dose was
related to maximum heart distance in the medial field.
Results: For left-sided breast cancer, mean heart dose estimated from individual CT-scans varied from
<1 Gy to >8 Gy, and maximum dose from 5 to 50 Gy for all three regimens, so that estimates based only
on regimen had substantial uncertainty. When maximum heart distance was taken into account, the
uncertainty was reduced and was comparable to the uncertainty of estimates based on individual CT-
scans. For right-sided breast cancer patients, mean heart dose based on individual CT-scans was always
<1 Gy and maximum dose always <5 Gy for all three regimens.
Conclusions: The use of stored individual simulator films provides a method for estimating heart doses in
left-tangential radiotherapy for breast cancer that is almost as accurate as estimates based on individual
CT-scans.
 2016 The Authors. Published by Elsevier Ireland Ltd. Radiotherapy and Oncology 119 (2016) 71–76.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/
by-nc-nd/4.0/).
Breast cancer is the commonest cancer among women world-
wide. It is usually diagnosed at an early stage and modern treat-
ment can involve several modalities including surgery,
chemotherapy, radiotherapy, endocrine treatment and anti-HER-
2 treatment, depending on the biomarker profile of the tumour.
A meta-analysis of data from randomised trials in early breast can-
cer has shown that, after breast conserving surgery, radiotherapy
to the conserved breast halves the rate of breast cancer recurrence
and reduces the breast cancer death rate by about a sixth [1]. These
effects are largely independent of other treatment modalities. The
randomised trials also show, however, that radiotherapy may
increase the risk of heart disease [2].
The radiation dose to the heart is usually larger in radiotherapy
for left-sided than for right-sided breast cancer, and several studies
have found that patients irradiated for left-sided breast cancer
have higher risks of heart disease than those irradiated for right-
sided breast cancer [3–6]. None of these studies included detailed
information on radiation doses to the heart. A recent case-control
study of Danish and Swedish women irradiated for breast cancer
during 1958–2001, in which cardiac dose was estimated for indi-
vidual women, showed that the rate of major coronary events
increased linearly with mean dose to the heart by 7.4% per Gy with
no apparent threshold below which there was no risk [7]. In the
case–control study, radiotherapy planning for most of the women
was performed using conventional simulators rather than individ-
ual CT planning. Radiation doses to the heart for these women
were, therefore, estimated using a ‘‘typical patient CT-scan” for
which the heart dose from a variety of different breast cancer
radiotherapy regimens was near the average. Each radiotherapy
regimen in the study was then reconstructed on this ‘‘typical
patient CT-scan” [8]. This method did not take into account likely
variations in cardiac dose from individual variations in patient
anatomy, setup errors or organ motion during treatment. It is,
however, possible to allow for individual variation in patient anat-
omy in women who received left-tangential radiotherapy using the
amount of heart in the fields on conventional simulator films
[9,10].
The first aim of the present study was, therefore, to evaluate the
variability in radiation doses to the heart due to anatomical
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differences, setup errors, and organ motion from 2D-tangential
radiotherapy in Denmark. The second aim was to examine the
use of conventional simulator films as a surrogate for individual
CT-scans to estimate individual radiation doses to the heart.
Material and methods
Reconstruction of radiotherapy plans
Since 1977, the national guidelines from the Danish Breast Can-
cer Cooperative Group (DBCG) have included technical breast can-
cer radiotherapy protocols [11] which are used by all Danish
radiotherapy centres. In order to learn how these protocols were
implemented in each centre, interviews were conducted (by ELL)
with present and former radiographers, oncologists, and physicists.
Three main regimens were used between 1982 and 2002. Based
on the nodal status the patient would receive one of the three tech-
niques (referred to as regimens A, B and C) as illustrated in Fig. 1.
For the tangential fields, the beam angle, collimator and custom
block were based on radiopaque wires marking 3 cm contralateral
to the mid-sternal line (regimens A and B) or the mid-axillary and
mid-sternal lines (regimen C), as well as the caudal borders of the
mammary tissue. A maximum of 3 cm of lung tissue, seen in
beam’s eye view, was allowed within the tangential fields. To
achieve dose homogeneity, a standard mix of 85% 6 MV photons
and 15% 18 MV photons with a 60 degree wedge was used. A pho-
ton field angled at 15 degrees contralaterally to the treated breast
was used for the periclavicular region for regimens A and B. The
prescribed dose was 48 Gy in 24 fractions. Further details on the
procedure for plan reconstruction are given in Appendix A.
CT-planning scans
Today, three-dimensional (3D) CT-based radiotherapy has
replaced two-dimensional (2D) conventional simulation in all Dan-
ish radiotherapy centres. In 3D CT-based radiotherapy, target vol-
umes and organs at risk are delineated. Radiopaque wires as
described above are still in use, and patient position remains the
same. Therefore, 2D-based radiotherapy regimens could be recon-
structed using CT-scans of recent breast cancer patients. Regimens
A and B used identical tangential fields and were therefore recon-
structed on the same patients. Twenty patients with left-sided and
five patients with right-sided breast cancer were selected from
patients treated at Odense University Hospital during 2010 for
these reconstructions. Twenty further left-sided and 5 further
right-sided patients were selected for reconstructing regimen C.
Selection was made at random from all patients with similar char-
acteristics to those for which the specific regimen was used
historically.
Dose calculation
The dose distributions from the reconstructed regimens were
calculated using the collapsed-cone algorithm in Pinnacle with a
2 mm resolution using a model of an Elekta accelerator, as used
for breast cancer radiotherapy in the 1990 s. The heart was
Fig. 1. Beam’s eye views for the three tangential radiotherapy regimens. Regimens A and B were both targeted at the conserved breast and internal mammary chain (IMC)
with opposing tangential fields (panel a) and differed only in the periclavicular region where an anterior field was targeted at the periclavicular and axillary lymph nodes for
regimen A (panel b) and the periclavicular lymph nodes only for regimen B (panel c). Regimen C was targeted at the conserved breast only, with opposing tangential fields
(panel d). For relating mean heart dose to the amount of the heart in the field, the maximum heart distance (MHD) orthogonal to the field edge was measured for the
tangential fields, as illustrated.
72 Heart doses from 2D breast cancer RT
delineated on the CT-scans using an automatic heart delineation
tool (ABAS – Atlas-based autosegmentation by Elekta). This atlas
was based on the heart contours of 15 breast cancer patients
whose hearts had been delineated according to published guideli-
nes [12,13]. The ABAS automatic heart delineations have been ver-
ified in a separate study showing good performance when
compared with manual delineations [14]. The delineations and
dose distributions were imported into Matlab R2007b and anal-
ysed using the open-source tool CERR [15] and in-house code.
Setup errors and organ motion
The effects of setup errors and organ motion on heart dose were
simulated using a combination of random shifts and blurring of the
dose distribution in order to mimic systematic and random errors
respectively. Blurring was simulated by a 3D convolution of the
dose cube with a Gaussian distribution with standard deviation
(r), representing the total random error. The systematic errors
were simulated by shifting the blurred dose distribution 100 times
for each patient, with each shift representing a potential treatment
course for the patient. The shifts were drawn at random from a
Gaussian distribution with a standard deviation (R) representing
the total systematic error. Calculations were performed for
r = R = 1, 2, . . ., 10 mm. Mean heart dose was calculated for each
shift resulting, for each patient, in 100 estimates of the dose that
the patient could actually have received.
Estimation of heart dose using simulator films
To examine the potential value of simulator films for estimating
individual heart doses for patients with left-sided disease, digitally
reconstructed radiographs (DRRs) were generated and the maxi-
mum distance that the heart protruded into the medial field (max-
imum heart distance: MHD) was measured, as illustrated in Fig. 1,
panels (a) and (d). The MHD was measured perpendicularly to the
field edge at source-skin distance (SSD) = 100 cm. The natural log-
arithm of the mean heart dose was then related to MHD using lin-
ear regression.
Error in estimated mean heart dose
The distribution of the mean heart doses that each patient could
actually have received, taking into account setup errors and organ
motion, was compared to the mean dose estimated using three dif-
ferent methods, based on increasing amounts of information: (1)
Regimen based: the median of the mean heart doses for each regi-
men, as estimated from the CT-based treatment planning scans
for the selected patients, (2) Film-based: individual estimates of
mean heart dose calculated from individual measures of MHD, as
derived from simulator films, and the linear regression relating
the logarithm of mean heart dose to MHD for the sampled patients,
and (3) CT-based: individual estimates based on the patient’s own
CT-scan.
Results
Mean and maximum heart doses for the three reconstructed
regimens, estimated using the individual CT-based planning scans
for the patients selected for the study, are presented in Fig. 2. For
right-sided patients the mean heart dose was always less than
1 Gy and the maximum dose always less than 5 Gy for all three
regimens. For left-sided radiotherapy, the heart doses were higher
and there was substantial inter-patient variation: mean doses ran-
ged from below 1 to more than 8 Gy and maximum doses ranged
from 5 to 50 Gy. The averages of both the mean and the maximum
doses were significantly higher for left-sided than for right-sided
treatments (average of mean doses: left-sided 3.50 Gy, right-
sided 0.78 Gy, p for difference: <0.0001; average of maximum
doses: left-sided 43.3 Gy, right-sided 3.14 Gy, p for difference:
<0.0001). Among left-sided patients, the heart doses from regimen
A were slightly larger than from regimen B while the doses from
regimen C were lower than from regimen B (average of mean
doses: 3.84, 3.83, and 2.82 Gy for regimens A, B and C respectively;
average of maximum doses: 43.8, 43.8, and 42.3 Gy). The differ-
ences between the three regimens were, however, not statistically
significant (p for heterogeneity: 0.23 and 0.88 for average mean
and maximum doses respectively).
Setup errors and organ motion
The distributions of the mean heart doses that each of the 40
patients with left-sided disease and 10 patients with right-sided
disease could actually have received for different assumptions
regarding the magnitude of the standard deviation due to setup
errors and organ motion are summarised in Fig. 3. For left-sided
patients, bigger standard deviations resulted in substantial
increases in the 95th percentiles of the mean heart dose, small
increases in the 75th percentiles and the medians and little change
in the 25th and 5th percentiles. Bigger standard deviations caused
little change in the 95th percentiles of the maximum heart dose for
left-sided patients, and reduced the medians and 75th, 25th and
5th percentiles. For right-sided patients, bigger standard devia-
tions increased the 95th percentiles of both mean and maximum
heart doses substantially, but had a much smaller effect on the
medians.
Fig. 2. Estimated heart doses for the three reconstructed techniques. Estimates are
based on the individual CT-based planning scans for the patients included in the
study. Mean dose (a) and maximum dose (b) for the three regimens (A, B and C) for
left-sided patients (20 for each regimen) and right-sided patients (5 for each
regimen).
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Estimation of heart dose using simulator films
For any particular values of random and systematic errors, the
distribution of individual mean heart doses was positively skewed
and so a logarithmic transformation (ln) was applied before further
analysis. Patient-specific averages of the simulated values of the ln
(mean heart dose) were then calculated. The dependence of these
patient-specific averages on MHD is shown in Fig. 4 for three sets
of mean heart doses, based on simulated setup and organ motion
errors of 0, 5 and 10 mm respectively. For all three error magni-
tudes ln(mean heart dose) and MHD were highly correlated (R2:
0.87, 0.87 and 0.85 for errors of 0 mm, 5 mm and 10 mm respec-
tively) and the residuals showed no evidence of departure from a
linear relationship. The effect of radiotherapy regimen (as indi-
cated by the inclusion in the regression of a categorical variable
with three levels) was not significant (p = 0.65, 0.91, and 0.98 for
errors of 0 mm, 5 mm and 10 mm respectively).
Error in estimated mean heart dose
For patients with left-sided disease, Fig. 5 shows the root mean
square error (RMSE) of the estimated mean heart doses compared
with estimates of the doses that the patients could actually have
Fig. 3. Distribution of the mean heart doses that each patient could actually have received, taking into account setup errors and organ motion, as well as the effect of
positional variability derived from the individual CT-scans. The standard deviations of the random (r) and systematic (R) errors were assumed to be equal (r = R) and the
simulations were performed with values in the range of 0 to 10 mm. For each patient and each regimen, 100 mean doses received were simulated for each value of the
standard deviation considered, giving 100  20 doses for left-sided breast cancer at each value of the standard deviation (100  5 values for right-sided). The median value of
these simulated doses and the 5th, 25th, 75th and 95th percentiles are shown as a function of the standard deviation. A standard deviation of zero corresponds to the
distribution of doses shown in Fig. 2.
Fig. 4. Relation between mean heart dose actually received and maximum heart
distance (MHD) for patients with left-sided breast cancer. ln () denotes natural
logarithm, D is mean heart dose in Gy and D0 is set at 1 Gy. Crosses are patient-
specific averages of simulated values. Crosses, solid regression line and regression
equation assume a standard deviation of the random and systematic errors of 5 mm
(r = R = 5 mm). The regression lines assuming standard deviations of 0 mm and
10 mm are shown by the lower and upper dotted lines, respectively.
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received for the three different methods of dose estimation. For
estimates based on regimen only, the RMSE was substantial, espe-
cially for patients with MHDs in the highest or lowest quintile. For
the film-based estimates, the RMSEs were much lower, and compa-
rable to those for the CT-based estimates. For the CT-based esti-
mates, the RMSE values reflect only the effect of setup and organ
uncertainties. These were around 0.5 Gy for patients with MHD
in the lowest quintile, 1–1.5 Gy for patients with in the middle
three quintiles, and around 2 Gy for patients with MHD in the
highest quintile.
Discussion
This study shows that there is substantial uncertainty in esti-
mating heart doses from left-sided 2D-tangential radiotherapy
for Danish breast cancer patients treated from 1982 to 2002 using
only information on prescribed dose, laterality (left–right) and reg-
imen. The use of individual simulator films provides an alternative
method for which the uncertainty is markedly reduced and is, in
fact, close to the uncertainty expected when individual CT-based
estimates are used.
Several studies of heart disease after radiotherapy for breast
cancer have used left-versus-right comparisons [3–6] because radi-
ation doses to the heart are usually higher for left-sided than for
right-sided radiotherapy due to the anatomical position of the
heart. Correa et al. [16] measured proportions of heart and lung tis-
sue in the radiation field for patients given cardiac diagnostic tests
after radiotherapy and found that significantly more lung tissue
was included in the field for patients with cardiac abnormalities
versus patients without cardiac abnormalities. Using details
regarding the targets irradiated, Nilsson et al. [17] found an associ-
ation between areas of expected high radiation dose in the heart
and later location of stenosis in the coronary arteries. However,
none of these studies attempted to estimate heart doses from the
treatments.
Darby et al. [7] showed that the relationship between mean
dose to the heart from breast cancer radiotherapy and subsequent
risk of ischaemic heart disease was linear. However, the dosimetry
methods used in that study [18] did not take into account individ-
ual anatomical variations, setup errors, or organ motion during
treatment. The present study was, therefore, conducted to estimate
the effect of these uncertainties. The results will enable a more pre-
cise estimation of dose–response relationships in the future, partly
because it will be possible to use the average of 20 estimates for
each regimen instead of just one estimate on a representative
patient and, most importantly, because the use of simulator films
will reduce considerably errors in estimated dose compared to a
regimen-specific average value (Fig. 5).
Mean heart dose from left-sided tangential radiotherapy vary
substantially because the heart is located near the field border.
Therefore small differences in the heart position relative to the
tangential fields have a major impact on the heart dose. Two
wide tangential regimens (A and B) differed only in the periclav-
icular region and therefore delivered nearly identical heart doses.
Heart doses from tangential radiotherapy with the medial border
on the mid-sternal line (regimen C) were slightly lower, but did
not differ significantly from doses from the wide tangential reg-
imens. One explanation for this relatively small difference is the
constraint of a maximum of 3 cm of lung in field, which tended
to limit the heart dose. Compared to previous estimates of heart
doses on a representative patient [18], the doses obtained in the
present study are on average lower, but they have large inter-
patient variation.
In a recently published quality assurance study from the DBCG
[19], heart doses were estimated for breast cancer radiotherapy
used since 2003 by reconstructing radiotherapy on CT-scans of
newly diagnosed breast cancer patients, as performed in our study.
Two of the techniques reconstructed in that study are similar to
the left-sided regimen C and right sided regimen A/B in our study.
Similar doses were indeed found in that study with average mean
heart doses of 0.8 Gy for right-sided regimen A/B and 3.4 Gy for
left-sided regimen C.
Setup errors and organ motion
During the period considered in this study, all centres used
port films for setup verification at the first fraction, and a few
centres used additional setup verification halfway through the
treatment course. A total standard deviation of 3–4 mm for both
random and systematic uncertainties was estimated by combin-
ing the results from a published study of the uncertainty of heart
position relative to the breast [20] and simulated historical setup
uncertainty based on orthogonal images (kV or Mv) of 413
present-day breast cancer patients [21]. These studies were, how-
ever, based on electronic imaging devices whereas film-based
portal imaging was used in the pre-CT era. Using port films
was more time-consuming and less accurate due to the time
delay between exposure and the manual evaluation, and a higher
total uncertainty in the order of 4–5 mm would be expected with
port films. Knowing the exact value is, however, not critical as
the effect on the doses for errors of around 5 mm is limited, as
shown in Fig. 3.
Estimation of heart dose using simulator films
One other study has evaluated the relationship between maxi-
mum heart distance and later heart disease [6]. It found no statis-
tically significant relationship but, with only 139 events in left-
sided patients, the study had limited power. In the present study,
using MHD as the only explanatory variable in a simple linear
model provided a good correlation with the logarithm of mean
heart dose, in line with findings in previous studies [9,10]. Taylor
et al. [9] found the relationship between MHD and mean heart
dose to be: 2.9 Gy/cmMHD + 4.1 Gy whereas Kong et al. [10] found
Fig. 5. Root-mean-squared error (RMSE) of the estimated mean heart doses for left-
sided patients compared with received mean heart doses. Received mean heart
doses were calculated from the individual CT-based planning scans for the patients
included in the study together with simulated organ motion and setup errors,
assuming a standard deviation for both random and systematic errors of 5 mm.
Mean heart doses were estimated by three different methods based on increasing
amounts of information: (1) regimen-based, (2) film-based (assuming
r = R = 5 mm, as shown in Fig. 4), and (3) CT-based (but ignoring any setup
uncertainties and organ motion). The 40 left-sided patients were divided in five
equally sized groups according to the MHD and for each group the RMSE for each
method is shown.
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it to be: 2.8 Gy/cm MHD + 2.2 Gy. In the present study the doses
were log transformed to account for the skewed distribution of
mean heart doses but, for comparison we performed linear regres-
sion analysis based on mean dose in Gy, resulting in the following
relationship: 2.43 Gy/cm MHD + 0.42 Gy for r = R = 0 mm. Hence,
given the differences in the prescribed dose, radiotherapy tech-
niques and dose calculation algorithms, there is good agreement
between these dosimetric studies.
Error in estimated mean heart dose
The simulations of setup error and organ motion enabled the
differences between estimated doses and the doses likely to have
been received to be studied. When using the regimen-specific
median estimate the errors were large for the group of patients
receiving the highest doses, with an RMSE of approximate 4.5 Gy
(see Fig. 5). Using MHD as predictor reduced this error, especially
for the high-dose patients where the RMSE was more than halved.
Using individual doses, corresponding to the planned dose in CT-
based radiotherapy, resulted in only a slight further reduction of
the RMSE. Using MHD or CT-based estimates in preference to
regimen-specific estimates would be especially important in stud-
ies where distribution of heart doses may not be representative of
that in the general irradiated breast cancer population, such as for
the cases in a case-control study of radiation-related heart disease.
Conclusions
The mean heart doses from right-sided tangential radiotherapy
used in the pre-CT era were less than 1 Gy for all patients in the
study, whereas the heart doses for left-sided radiotherapy were
higher with large inter-patient variation. Estimates of heart doses
for women treated in the pre-CT era based on radiotherapy regi-
men and laterality only, have large uncertainty for patients who
received left-tangential radiotherapy. Stored individual simulator
films enable prediction of mean heart dose of left-sided patients
with an accuracy close to that expected from individual CT-based
estimates.
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